Mark Shawn Frank is Director at ProPhase Labs, Inc. (PRPH). They have made 1 open-market trade across 1 company since 2013, most recently 2015-01-02.
CIK 0001466346
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $33K since 2013, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PRPH | 79,235 | $29K |
Shares reported on the most recent Form 4, priced at the 2015-01-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PRPH | BUY | 2013-05-23 | 2013-05-28 | $1.65 | $33K | -4.9% | -2.8% | -2.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.